FY2024 Earnings Forecast for MGRM Issued By Roth Capital

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Equities research analysts at Roth Capital issued their FY2024 earnings per share (EPS) estimates for Monogram Orthopaedics in a research note issued to investors on Monday, December 9th. Roth Capital analyst J. Wittes expects that the company will post earnings of ($0.50) per share for the year. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.48) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ Q4 2024 earnings at ($0.12) EPS, Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.11) EPS, Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.15) EPS, FY2025 earnings at ($0.49) EPS, Q1 2026 earnings at ($0.12) EPS, Q2 2026 earnings at ($0.13) EPS, Q3 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.49) EPS, FY2027 earnings at ($0.28) EPS and FY2028 earnings at $0.06 EPS.

Separately, Roth Mkm initiated coverage on Monogram Orthopaedics in a research report on Monday. They issued a “buy” rating and a $4.00 price target for the company.

Monogram Orthopaedics Trading Down 1.2 %

Shares of Monogram Orthopaedics stock opened at $2.57 on Wednesday. The firm has a market capitalization of $88.18 million, a P/E ratio of -5.47 and a beta of 2.00. The business’s fifty day simple moving average is $2.27 and its 200 day simple moving average is $2.40. Monogram Orthopaedics has a 12 month low of $1.53 and a 12 month high of $4.90.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in MGRM. Barclays PLC purchased a new stake in shares of Monogram Orthopaedics in the 3rd quarter worth approximately $29,000. State Street Corp purchased a new stake in shares of Monogram Orthopaedics in the 3rd quarter worth approximately $62,000. Finally, Geode Capital Management LLC boosted its stake in Monogram Orthopaedics by 1,267.4% during the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after purchasing an additional 194,776 shares during the last quarter. Institutional investors own 0.45% of the company’s stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.